A Covid-19 antibody test developed at Lausanne university hospital (CHUV) has been chosen for wide-scale studies of the Swiss population, the hospital has announced.
This content was published on
1 minute
Keystone-SDA/jc
Selection of a single serology test was necessary for consistent and comparable data at national level, CHUV said on Thursday.
The hospital announced in June that one of its teams had developed a new coronavirus antibody blood test in collaboration with the Federal Institute of Technology Lausanne (EPFL) and the Swiss Vaccine Research Institute.
“Compared to other commercially available tests, the technology developed at the CHUV has a 15-30% higher sensitivity, making it possible to detect antibodies to SARS-CoV-2 long after infection, even in people with few or no symptoms,” CHUV said in a press release.
Corona Immunitas, the government-backed antibody testing programme, has now chosen it for nationwide tests. Supported by the Federal Office of Public Health (FOPH), Corona Immunitas is in charge of coordinating more than 20 population studies to estimate the number of people infected with SARS-CoV-2 in Switzerland.
Such studies are very useful from an epidemiological point of view and may also help determine immunity levels to the virus.
Popular Stories
More
Swiss Abroad
The citizenship obstacle course facing spouses of Swiss Abroad
What factors should be taken into account when inheriting Swiss citizenship abroad?
Should there be a limit to the passing on of Swiss citizenship? Or is the current practice too strict and it should still be possible to register after the age of 25?
Swiss Senate committee wants to stop UNRWA funding
This content was published on
Switzerland should stop payments to the United Nations Relief and Works Agency for Palestine Refugees (UNRWA) immediately, according to a Senate committee.
This content was published on
Wind generated 160 million kilowatt hours (kWh) of electricity across Switzerland last year, according to the Swiss Wind Energy Association (Suisse-Eole). It was a "good year but less exceptional than 2023", it said.
Swiss authorities draw up new rules to manage PFAS
This content was published on
The Swiss federal authorities are working on drawing up regulations for toxic PFAS “forever chemicals”. A government report is expected by the end of the year.
This content was published on
Eugen Kägi, who helped build the family-run firm behind the popular chocolate-covered Kägi-fret wafers, died on February 13, aged 96, it was announced on Tuesday.
Empty offices in Switzerland could house 43,000 people
This content was published on
Empty office buildings in Switzerland could in theory accommodate 43,000 people, according to a report by Swiss public television, RTS.
UBS among leading non-US investors in nuclear weapons producers, says study
This content was published on
The number of financial institutions funding major nuclear weapons manufacturers continues to fall, a new report shows. The Swiss bank UBS bank is one of the top 30 investors.
Around 68,000 Ukrainian refugees live in Switzerland
This content was published on
Three years after the outbreak of the war in Ukraine, almost 68,000 Ukrainians are currently living in Switzerland as refugees with protection status S.
English and other foreign languages on rise in Switzerland
This content was published on
The proportion of people in Switzerland whose main language is not one of the four national languages – German, French, Italian or Romansh - has risen significantly in recent years.
Police bust drug trafficking ring in southern Switzerland
This content was published on
Valais cantonal police have broken up a major drug trafficking ring in the Sierre region in southern Switzerland. Thirty people, including minors, have been arrested.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Switzerland mulls controversial Covid-19 health passports
This content was published on
Swiss technology firms and medical researchers are developing digital health passports that could be used to certify who is immune to Covid-19.
Roche in talks with Britain on Covid-19 antibody test
This content was published on
Britain is in talks with Swiss drugmaker Roche on rolling out an accurate Covid-19 antibody test that it said could be a game changer.
This test could help Switzerland get back on track
This content was published on
While we await a vaccine or treatment, scientists are developing tests to tell us how widespread the virus is, such as the serological test.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.